Disruptive technology and hemophilia care : the multiple impacts of emicizumab

Hermans, C. and Makris, M. orcid.org/0000-0001-7622-7939 (2021) Disruptive technology and hemophilia care : the multiple impacts of emicizumab. Research and Practice in Thrombosis and Haemostasis.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2021 The Authors. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: care; disruptive technology; emicizumab; hemophilia; inhibitor; nonreplacement therapy
Dates:
  • Accepted: 26 February 2021
  • Published (online): 7 May 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 13 May 2021 06:40
Last Modified: 13 May 2021 06:40
Status: Published online
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1002/rth2.12508

Share / Export

Statistics